Missing: InnerPulse's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: InnerPulse's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Latest InnerPulse News
May 13, 2016
Implantable Cardioverter Defibrillators (ICD) Medical Devices Pipeline Assessment, 2016 - Analysis, Technologies & Forecasts Report - Key Vendors: AIS, InnerPulse, Medtronic - Research and Markets May 13, 2016 09:55 AM Eastern Daylight Time DUBLIN--( BUSINESS WIRE )--Research and Markets has announced the addition of the "Implantable Cardioverter Defibrillators (ICD) - Medical Devices Pipeline Assessment, 2016" drug pipelines to their offering. Implantable Cardioverter Defibrillators (ICD) - Medical Devices Pipeline Assessment, 2016 Our Medical Devices sector report, Implantable Cardioverter Defibrillators (ICD) - Medical Devices Pipeline Assessment, 2016" provides an overview of Implantable Cardioverter Defibrillators (ICD) currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Implantable Cardioverter Defibrillators (ICD) pipeline products. This report is prepared using data sourced from in-house databases, secondary and primary research by our team of industry experts. Key Topics Covered: Extensive coverage of the Implantable Cardioverter Defibrillators (ICD) under development The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities The report reviews the major players involved in the development of Implantable Cardioverter Defibrillators (ICD) and list all their pipeline projects The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage The report provides key clinical trial data of ongoing trials specific to pipeline products Recent developments in the segment / industry Companies Mentioned:
InnerPulse Frequently Asked Questions (FAQ)
When was InnerPulse founded?
InnerPulse was founded in 2003.
Where is InnerPulse's headquarters?
InnerPulse's headquarters is located at 4025 Stirrup Creek Drive, Durham.
What is InnerPulse's latest funding round?
InnerPulse's latest funding round is Series C.
How much did InnerPulse raise?
InnerPulse raised a total of $85.1M.
Who are the investors of InnerPulse?
Investors of InnerPulse include Frazier Healthcare Partners, Johnson & Johnson Innovation, Delphi Ventures, Synergy Life Science Partners, Medtronic and 9 more.
Who are InnerPulse's competitors?
Competitors of InnerPulse include Uromedica, Cyberheart, Vertiflex, Interlace Medical, Ablation Frontiers and 13 more.
Compare InnerPulse to Competitors
Ouroboros Medical is a medical devices for minimally invasive spinal fusion
Uromedica develops minimally invasive medical devices that treat unmet medical needs in the area of urinary incontinence and related disorders. Products (sold under the ACT and ProACT brands) are based on adjustable balloon technology. Conditions being treated are post-prostatectomy incontinence in men and stress incontinence in women (after earlier interventions have failed).
OrSense provides non-invasive monitoring of various blood constituencies.
NeuroSonix is an Israeli medical device company targeting the market of cerebral embolic protection during cardiac surgical and other minimally invasive procedures. NeuroSonix has conceived, developed and patented a technology and medical devices for the prevention of acute cerebral embolism during open-heart cardiac surgery as well as other invasive and minimally-invasive procedures. The company's technology, which is based on ultrasound, aims to enable a non-invasive deflection of embolic material flowing inside the body, away from the cerebral arteries. This new ultrasonic modality aims to reduce the embolic load on the patient's brain. The first product developed by the company is the EmBlocker"ž, intended to provide protection from acute cerebral embolism during cardiac surgical procedures. The Protection Collar, the company's second product, is intended for embolic protection during minimally-invasive procedures and Cath-lab practice.
Ouroboros develops medical devices for minimally invasive spinal fusions.
Axis Surgical Technologies, Inc. aims to develop, manufacture, and market devices that improve quality and efficiency in spinal surgery, especially for minimally invasive surgical techniques. Based in Mountain View, California, Axis offers an integration of visualization and articulation capabilities and provides spinal surgery equipment.Axis' FDA Grant In March 2010, Axis announced that it received 510(k) clearance from the Food and Drug Administration to market its C-MOR„ Visualization Device to use in diagnostic and operative arthroscopic and endoscopic procedures. This portable tool provides visualization and illumination of an interior cavity through either a natural or surgical opening. The ergonomic lightweight device also offers practitioners the convenience of endoscopic visualization and efficient one-handed operating ability; this device can be employed in hospital outpatient departments, ambulatory surgery centers, and office surgery suites.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.